Health
Existing drug masitinib identified as potential inhibitor of SARS-CoV-2 – News-Medical.Net
Researchers in the United States have demonstrated that a drug originally developed as a treatment for cancer exhibits antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COV…
Researchers in the United States have demonstrated that a drug originally developed as a treatment for cancer exhibits antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
The drug, which is called masitinib, potently inhibited the main viral protease 3CLpro that SARs-CoV-2 relies on for infection to proceed once the viral genome has entered the host cell cytoplasm.
The study showed that masitinib di…
-
Noosa News23 hours agoBody found on Palm Beach as police call on public for help to identify elderly woman
-
Noosa News24 hours agoHighway closed as four killed, two critically injured in horror smash at Blackwater west of Rockhampton
-
Noosa News22 hours agoBrisbane’s new QPAC theatre name revealed following public poll
-
General19 hours agoTwo men killed in plane crash west of Brisbane